Top Markets
#1 DogBull DogBull +36.46%
#2 The Bitcoin Bull The Bitcoin Bull +31.37%
#3 Siacoin Siacoin +27.38%
#4 Merlin's Seal BTC Merlin's Seal BTC +25.80%
#5 Cash Cat Cash Cat +19.34%
#6 Ontology Gas Ontology Gas +18.55%
#7 MarsCoin MarsCoin +17.63%
#8 Pons Pons +17.48%
#9 Akedo Akedo +11.80%
#10 Uniswap Uniswap +11.35%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Global Cord Blood Corporation Global Cord Blood Corporation

Global Cord Blood Corporation

CO
Rank in Stocks #14665
Global Cord Blood Corporation (GCBC), alongside its associated entities,... Global Cord Blood Corporation (GCBC), alongside its associated entities, provides specialized services related to umbilical cord blood within the People's Republic of China. The company's operations involve the testing, processing, and long-term storage of cord blood for both private subscribers and donated samples. For the latter, it also facilitates donor matching. As of March 31, 2022, GCBC managed three cord blood banks situated in key regions: Beijing municipality, Guangdong province, and Zhejiang province. The company, which is headquartered in Central, Hong Kong, rebranded as Global Cord Blood Corporation in March 2018, having previously been known as China Cord Blood Corporation. Currently, it functions as a subsidiary under Blue Ocean Structure Investment Company Ltd.
Share Price
$2.99
Last synced: 2023-06-09
Market Cap
$400.08M
Change (1 day)
174.09%
Change (1 year)
0.00%
Country
HK
Trade Global Cord Blood Corporation (CO)

Category

Healthcare
Revenue for Global Cord Blood Corporation (CO)
Revenue in Sep 2026 TTM: 0
According to Global Cord Blood Corporation latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Global Cord Blood Corporation from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $46.34B -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $25.11B -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $2.71B -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $4.55B -
US